Brief: SEC Says "Effective" For Business Combination Of Larkspur Health Acquisition Corp And Zyversa Therapeutics
15/11/2022 12:46
Nov 15 (Reuters) - Larkspur Health Acquisition Corp
LSPR.O :
* SEC DECLARES FORM S-4 REGISTRATION STATEMENT "EFFECTIVE"
FOR
PROPOSED BUSINESS COMBINATION OF LARKSPUR HEALTH ACQUISITION
CORP., INC. WITH ZYVERSA THERAPEUTICS, INC.
Source text for Eikon: ID:nPn1hB8fMa
Further company coverage: LSPR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Zyversa Therapeutics
See all newsBrief: ZyVersa Therapeutics Announces Share Purchase Agreement for up to $10 Million
Brief: ZyVersa Unveils Potential Of Inflammasome Inhibitors In Combination With GLP-1 Agonists To Address Needs Of People Living With Obesity
Brief: Zyversa Therapeutics Announces Published Data Showing Inflammasome Asc Inhibitor IC 100 Decreases Microglial Inflammasome Activation
Brief: ZyVersa Therapeutics CEO Issues Shareholder Letter Announcing Transformative Research And Development Trends For Inflammasome Inhibitors, And Provides Update On Inflammasome ASC Inhibitor IC 100’S Development Status
Brief: Zyversa Therapeutics Files For Prospectus Related To Offer & Resale Of Up To 1.6 Million Shares Of Common Stock By Selling Stockholder - SEC Filing